Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation
Risk stratification in myelodysplastic syndromes myelodysplastic syndromes:
Myelodysplastic Syndromes (MDS)
A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study
Patients at risk for progression from myeloid precursor states (idiopathic cytopenia cytopenia: (sie-tuh-PEE-nee-uh) A shortage of one or more blood cell types. Also called a low blood count.
Transplant Associated Thrombotic Microangiopathy (TA-TMA)
Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric Bone Marrow Failure Diseases
Related Bone Marrow Failure Diseases and Malignancies
Presenter(s)
Sumithira Vasu, MD
During this webinar, Dr. Sumithira Vasu will discuss the diagnosis, treatment, and impact of transplant-associated thrombotic microangiopathy (TA-TMA). After the presentation, there will be a question-and-answer session. Questions can be submitted in advance to help@aamds.org.
11th AAMDSIF and Fred Hutch Cancer Center Conference on Aplastic Anemia, MDS/AML, MPN and PNH 9:05 AM PT - 4:15 PM PT
Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Bone Marrow Transplant
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
11th AAMDSIF and Fred Hutch Cancer Center Conference on Aplastic Anemia, MDS/AML, MPN and PNH 9:05 AM PT - 4:15 PM PT AAMDSIF and Fred Hutch Cancer Center are pleased to present the 11th Patient Conference, focusing on Aplastic Anemia, MDS, MPN, and PNH. After the presentations…
Reshma Ramlal, MD
Institution
Moffitt Cancer Center
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Reshma Ramlal is a hematologist-oncologist at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. She specializes in bone marrow transplantation and cellular immunotherapy, with a clinical and research focus on allogeneic transplantation for myeloid malignancies, including acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. She is particularly recognized for advancing safe and effective transplantation in the elderly population, offering individualized treatment plans that emphasize both survival and quality of life. In her clinical
Treatments for High Risk MDS and Secondary AML, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium
Topic(s)
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Hetty Carraway, M.D.
Amer Zeidan, MBBS
Mikkael Sekeres, MD, MS
Andrew Brunner
Maximilian Stahl, MD
Richard M. Stone, MD
Amer Zeidan, MBBS
The session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Co-Chairs Hetty Carraway, MD, MBA, FACP, and Amer Zeidan, MBBS, MD. Topics and Speakers included: Key Concepts in Clinical Trial Design For HR-MDS: Lessons Learned from Phase 3 -…
Treatments for Low Risk MDS and CCUS, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Neal Young, MD
Rena Buckstein, MD, FRCP
Valeria Santini, MD
Guillermo Garcia-Manero, MD
The session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, with Session Co-Chairs Rena Buckstein, MD, FRCPC, and Valeria Santini, MD. Sessions and speakers included: Reframing MDS and CHIP - Neal Young, MD Supportive Care in MDS –…
Health-Related Quality of Life, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium
Presenter(s)
Namrata Chandhok, MD
Thomas LeBlanc, MD, MA
Fabio Efficace, PhD
Alison R. Kavanaugh
Pamela C. Egan, MD
Wil L. Santivasi, MD
The session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Co-Chairs Namrata Chandhok, MD, and Thomas LeBlanc, MD, MA Topics and speakers included: How can we measure quality of life in MDS, to inform interventions? - Fabio Efficace, PhD…
MDS Classification and Prognosis, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Maria Creignou, MD
Matteo Della Porta, MD
Luca Lanino, MD
Carmelo Gurnari, MD
This session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Mateo Delia Porta, MD, and Elsa Bernard, PhD. Topics and speakers included: State of the Art for prognostication in MDS (not including AI) - Maria Creignou, MD, PhD State of the…
MDS and Secondary AML Pathophysiology, AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium
Topic(s)
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Jaroslaw Maciejewski, MD, PhD
Valeria Visconte, PhD
Lukasz Gondek, M.D., Ph.D.
Guillermo Montalban Bravo, MD
Aly Karsan, MD
This session was recorded at the AAMDSIF 2026 International Bone Marrow Failure Scientific Symposium, Co-Chairs Jaroslaw Maciejewski, MD, PhD, and Maria (Ken) Figueroa, MD. Session topics and speakers included: Objective pathogenetically driven molecular classification of MDS and…